Evidence map›Paper›PMID 34061597›Full record

ArticlemBio2021

Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides.

Lars J Lindstad, Galiana Lo, Shaun Leivers, Zijia Lu, Leszek Michalak, Gabriel V Pereira, Åsmund K Røhr, Eric C Martens, Lauren S McKee, Petra Louis and 4 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Applied and environmental microbiology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. mGem:mBio · 2026
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Lars J LindstadFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Galiana LoGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
Shaun LeiversFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Zijia LuDivision of Glycoscience, Department of Chemistry, KTH Royal Institute of Technology, AlbaNova University Centre, Stockholm, Sweden.
Leszek MichalakFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Gabriel V PereiraDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Åsmund K RøhrFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Eric C MartensDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Lauren S McKeeDivision of Glycoscience, Department of Chemistry, KTH Royal Institute of Technology, AlbaNova University Centre, Stockholm, Sweden.
Petra LouisGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
Sylvia H DuncanGut Health Group, Rowett Institute, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
Bjørge WesterengFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Phillip B PopeFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Sabina Leanti La RosaFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Aas, Norway.
Norwegian University of Life Sciences · NOUniversity of Aberdeen · GBAlbaNova · SEUniversity of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Mannans are hemicelluloses that are abundant in modern diets as components in seed endosperms and common additives in processed food. Currently, the collective understanding of β-mannan saccharification in the human colon is limited to a few keystone species, which presumably liberate low-molecular-weight mannooligosaccharide fragments that become directly available to the surrounding microbial community. Here, we show that a dominant butyrate producer in the human gut, Faecalibacterium prausnitzii, is able to acquire and degrade various β-mannooligosaccharides (β-MOS), which are derived by the primary mannanolytic activity of neighboring gut microbiota. Detailed biochemical analyses of selected protein components from their two β-MOS utilization loci (F. prausnitzii β-MOS utilization loci [

Indexed as

BacteroidesColonDietEubacterialesFaecalibacterium prausnitziiGastrointestinal MicrobiomeHumansMannansMetagenomicsOligosaccharidesMannansOligosaccharidesbutyrate producercarbohydrate active enzymescross-feeding interactionshuman gut microbiotashort-chain fatty acidsβ-mannanβ-mannoligosaccharides

Identifiers

PMID34061597
PMCPMC8262883
OpenAlexW3164444785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.